-
STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication
SEOUL, South Korea, July 1, 2026 /PRNewswire/ — STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for a thyroid-specific indication (510(k) number: K252833). The clearance took effect on 26 May 2026. The company’s system may now…
-
Jelly Force Male Enhancement Gummies Release Latest Formula for Men: JellyForce Unique Ingredient Profile Report
Pinellas Park, FL, July 02, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. JellyForce is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use, especially if currently taking prescription medications. JellyForce is a gummy dietary supplement formulated for men,…
-
Green Agriculture Chain Section at the 4th CISCE: AI-Driven Innovation Across Global Agri-Food Supply Chains
BEIJING, June 25, 2026 /PRNewswire/ — The Green Agriculture Chain section of the fourth China International Supply Chain Expo (CISCE) brought together more than 100 agribusinesses from around the world. Focused on the future of technology-enabled agriculture, the section showcased innovations spanning the agricultural value chain and provided an international exchange platform to safeguard global…
-
Agthia Launches “FUELL” – World’s First Energy Drink Sweetened with Dates
ABU DHABI, UAE, June 16, 2026 /PRNewswire/ — Agthia Group PJSC, the region’s leading food and beverage company, today announced the launch of Fuell, the world’s first energy drink sweetened with dates, bringing a distinctly Emirati perspective to the global energy drink category. Fuell combines date-based sweetness with functional ingredients such as guarana and Korean red…
-
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. JellyFil is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the U.S. Food and Drug Administration. BreathEaseX is not intended to diagnose, treat, cure, or prevent any disease. Consumers should consult a qualified healthcare professional before using any dietary supplement, particularly if currently taking prescription medications or managing existing health…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
New ‘World Football Food’ cookbook gives fans a culinary kick-off to Word Cup 2026
Simple snacks, mains and sides from all 48 competing nations to get fans cooking 200 pages, 288 recipes – lets fans delve into the culture of world football food Team and tournament insights, recipes and schedule EMAIL AUTHOR WILL GRAY TO DISCUSS BESPOKE FEATURES / STORIES ON THIS TOPIC London, UK (7 May, 2026) Football fans will get…
-
Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time
Company sets a benchmark again in pharmaceutical excellence reinforcing its global leadership in quality and regulatory compliance Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, with Zero adverse observations (No Form 483 issued…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
